KRAS and leukemia: Remaining candidates (N = 62) comprised BDNF-related genes (SST), MAPK-pathway genes (KRAS, IGF1R, GNG11 and RAP1A), genes related with leukemia (SFRP1) and Rho-Proteins (DHCR7 and RAB21).